Now that the patent has expired, this cancer drug is suddenly 99% cheaper
The patent on the cancer drug Revlimid (lenalidomide) recently expired. Whereas a few weeks ago a pack still cost over 4,500 euros, after generic competition …
Amsterdam Medical Center creates ‘hijacked’ medicine
By Lucien Hordijk and Daan Marselis Using a set of legal tricks, the pharmaceutical industry was able to turn an animal gallic acid into a …
Brussels pressured drug regulator to approve Pfizer vaccine
Leaked documents show that the European Commission put pressure on the European Medicines Agency to approve the first Covid-19 vaccines simultaneously with the American FDA. …
Covid-19: EU countries spent over €220m stockpiling remdesivir despite lack of effectiveness
The drug’s manufacturer was aware of the negative results of the Solidarity trial before the European Commission struck a procurement deal with it, finds an …
Women not underrepresented in clinical trials
A Dutch advocacy group claims that women receive worse care than men, because pharmaceutical companies do not sufficiently test their medicines on women. A shocking …
‘As long as it is for free’
By Lucien Hordijk & Daan Marselis Most of the demand for (refresher) training courses for doctors in the Netherlands is fulfilled by industry- sponsored programmes. …
From blockbuster to nichebuster
Two decades of EU market protection of ‘orphan’ (rare disease) medicines have greatly benefitted the industry. According to research by The Investigative Desk, published in …
EMA rewrites medicine approval policy
New innovative medicines should be made available to European citizens more quickly. That is why the European Medicines Agency updates the process for market authorisation. …
